The global pancreatic cancer market was valued at USD 2.86 billion in 2024 and is projected to reach USD 10.25 billion by 2034, growing at a CAGR of 13.62%. Key drivers include advancements in immunotherapies and early diagnostic technologies. https://www.datamintelligence.com/research-report/pancreatic-cancer-market